These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30953486)

  • 21. Prediction of effective drug combinations by chemical interaction, protein interaction and target enrichment of KEGG pathways.
    Chen L; Li BQ; Zheng MY; Zhang J; Feng KY; Cai YD
    Biomed Res Int; 2013; 2013():723780. PubMed ID: 24083237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovering patterns in drug-protein interactions based on their fingerprints.
    Luo W; Chan KC
    BMC Bioinformatics; 2012 Jun; 13 Suppl 9(Suppl 9):S4. PubMed ID: 22901089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlated sequence-signatures as markers of protein-protein interaction.
    Sprinzak E; Margalit H
    J Mol Biol; 2001 Aug; 311(4):681-92. PubMed ID: 11518523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting DNA binding protein-drug interactions based on network similarity.
    Wang W; Lv H; Zhao Y
    BMC Bioinformatics; 2020 Jul; 21(1):322. PubMed ID: 32689927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale prediction of drug-target relationships.
    Kuhn M; Campillos M; González P; Jensen LJ; Bork P
    FEBS Lett; 2008 Apr; 582(8):1283-90. PubMed ID: 18291108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-target interaction prediction by random walk on the heterogeneous network.
    Chen X; Liu MX; Yan GY
    Mol Biosyst; 2012 Jul; 8(7):1970-8. PubMed ID: 22538619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhance the performance of current scoring functions with the aid of 3D protein-ligand interaction fingerprints.
    Liu J; Su M; Liu Z; Li J; Li Y; Wang R
    BMC Bioinformatics; 2017 Jul; 18(1):343. PubMed ID: 28720122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Potential Drug-Disease Associations through Deep Integration of Diversity and Projections of Various Drug Features.
    Xuan P; Song Y; Zhang T; Jia L
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Response Prediction as a Link Prediction Problem.
    Stanfield Z; Coşkun M; Koyutürk M
    Sci Rep; 2017 Jan; 7():40321. PubMed ID: 28067293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug side-effect prediction based on the integration of chemical and biological spaces.
    Yamanishi Y; Pauwels E; Kotera M
    J Chem Inf Model; 2012 Dec; 52(12):3284-92. PubMed ID: 23157436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition.
    Wu G; Liu J; Yue X
    BMC Bioinformatics; 2019 Mar; 20(Suppl 3):134. PubMed ID: 30925858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction Prediction.
    Liu Y; Wu M; Miao C; Zhao P; Li XL
    PLoS Comput Biol; 2016 Feb; 12(2):e1004760. PubMed ID: 26872142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linear and Kernel Model Construction Methods for Predicting Drug-Target Interactions in a Chemogenomic Framework.
    Yamanishi Y
    Methods Mol Biol; 2018; 1825():355-368. PubMed ID: 30334213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modularity in protein complex and drug interactions reveals new polypharmacological properties.
    Nacher JC; Schwartz JM
    PLoS One; 2012; 7(1):e30028. PubMed ID: 22279562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization.
    Ezzat A; Zhao P; Wu M; Li XL; Kwoh CK
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(3):646-656. PubMed ID: 26890921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile.
    van Laarhoven T; Marchiori E
    PLoS One; 2013; 8(6):e66952. PubMed ID: 23840562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical-protein interactome and its application in off-target identification.
    Yang L; Wang KJ; Wang LS; Jegga AG; Qin SY; He G; Chen J; Xiao Y; He L
    Interdiscip Sci; 2011 Mar; 3(1):22-30. PubMed ID: 21369884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The extraction of drug-disease correlations based on module distance in incomplete human interactome.
    Yu L; Wang B; Ma X; Gao L
    BMC Syst Biol; 2016 Dec; 10(Suppl 4):111. PubMed ID: 28155709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HNet-DNN: Inferring New Drug-Disease Associations with Deep Neural Network Based on Heterogeneous Network Features.
    Liu H; Zhang W; Song Y; Deng L; Zhou S
    J Chem Inf Model; 2020 Apr; 60(4):2367-2376. PubMed ID: 32118415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
    Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
    BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.